News archive

• 11-03-2010
  Orphazyme announces the completion of its seed financing with Novo Seeds joining as investor
• 03-03-2010
  Lux Biosciences Receives Acceptance of Luveniq™ MAA Filing from European Medicines Agency
• 02-03-2010
  Archimedes Pharma announces major fundraising of GBP 65 million
• 02-03-2010
  AnaptysBio adds strategic collaboration with another leading global pharmaceutical company
• 26-02-2010
  Light Sciences Oncology Meets a Major Milestone in Aptocine Development with Target Enrollment in Phase 3 MCRC Trial
• 11-02-2010
  Amira Pharmaceuticals Announces Efficacy of LPA1 Antagonist in a Preclinical Model of Scleroderma
• 09-02-2010
  AnaptysBio announces strategic collaboration with Merck & Co., Inc.
• 08-02-2010
  Epitherapeutics raises DKK 10 M in an extended seed financing, LFI Life Science Investment joins Syndicate; LFI's Mette Kirstine Agger joins Board
• 05-02-2010
  Lux Biosciences Files for LUVENIQ™ Approval in US and Europe for Noninfectious Uveitis
• 04-02-2010
  7TM Pharma successfully conducts clinical phase I trial with its second generation CB1 receptor antagonist